The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.
On June 29, a National Academies of Sciences, Engineering, and Medicine committee on reforming federal regulation of U.S. research called on U.S. agencies to abandon a controversial proposal to update rules that protect human research participants, then wait for the president and Congress to create a new high-level commission to recommend improvements.
The proposal, which was released in 2015 and has received extensive criticism from science groups, “is marred by omissions, the absence of essential elements, and a lack of clarity,” the report states.
Many groups have already criticized the proposal. One issue, they say, is that it could create potentially unworkable systems for tracking approvals to use biological specimens taken from humans. Another concern is that the government has failed to make clear how certain systems would work.
It is not clear, however, whether NIH, the Obama administration, and lawmakers will be willing to put the brakes on the effort to update the Common Rule, which officials have been pushing to complete by the end of 2016.
Read full, original post: U.S. should abandon controversial effort to update human research rules, National Academies panel says
